AGTC - Applied Genetic Technologies Corporation

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 2.53
52-Week Change 3-13.50%
S&P500 52-Week Change 324.46%
52 Week High 34.9500
52 Week Low 32.2600
50-Day Moving Average 32.8918
200-Day Moving Average 33.4189

Share Statistics

Avg Vol (3 month) 3143.33k
Avg Vol (10 day) 3121.46k
Shares Outstanding 518.22M
Float 11.37M
% Held by Insiders 117.29%
% Held by Institutions 158.14%
Shares Short (Nov 29, 2019) 491.72k
Short Ratio (Nov 29, 2019) 41.19
Short % of Float (Nov 29, 2019) 40.51%
Short % of Shares Outstanding (Nov 29, 2019) 40.50%
Shares Short (prior month Oct 31, 2019) 462.92k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2019
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin -53.45%
Operating Margin (ttm)-61.81%

Management Effectiveness

Return on Assets (ttm)-10.58%
Return on Equity (ttm)-20.13%

Income Statement

Revenue (ttm)27.66M
Revenue Per Share (ttm)1.52
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)27.86M
EBITDA -15.82M
Net Income Avi to Common (ttm)-14.78M
Diluted EPS (ttm)-0.8210
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)71.11M
Total Cash Per Share (mrq)3.9
Total Debt (mrq)5.81M
Total Debt/Equity (mrq)8.55
Current Ratio (mrq)7.95
Book Value Per Share (mrq)3.73

Cash Flow Statement

Operating Cash Flow (ttm)-34.76M
Levered Free Cash Flow (ttm)-22.19M